Read more

October 10, 2023
2 min read
Save

Children with AD more likely to patch-test positive for allergic contact dermatitis

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Children with atopic dermatitis had more positive patch-test results compared with children without AD (2.3 vs. 1.9).
  • Authors recommend children with atopic dermatitis should obtain patch testing.
Perspective from Lynn Sikorski, DO

Children with vs. without atopic dermatitis are more likely to have positive patch-test reactions for allergic contact dermatitis, according to a study.

Allergic contact dermatitis (ACD) is often misconstrued as AD in children, and patch-testing is often not performed to diagnose.

Pediatric itch
Children with vs. without atopic dermatitis are more likely to have positive patch-test reactions for allergic contact dermatitis. Image: Adobe Stock.

In fact, according to Hadley Johnson, BS, of University of Minnesota Medical School, and colleagues, even though the estimated prevalence of ACD in children is 16.5%, this population receives less than 10% of patch tests.

Therefore, in this retrospective study, Johnson and colleagues determined if children with vs. without AD have a higher prevalence of ACD and which allergens are most common.

Using the Pediatric Allergic Contact Dermatitis Registry from 2018 to 2022, the researchers compiled general and patch-testing data on 912 children, 615 of whom had AD.

Demographic data showed that children with AD were more likely to have atopic comorbidities such as asthma (OR = 3.09; 95% CI, 2.02-4.72) and allergic rhinitis (OR = 1.94; 95% CI, 1.39-2.7). Prior to patch testing, children with AD also experienced longer durations of dermatitis than children without AD (4.1 years vs. 1.6 years; P < .0001).

During patch testing, children with AD proved to have a higher number of positive reactions (OR = 1.57; 95% CI, 1.14-2.14) and positive results overall (2.3 vs. 1.9; P = .012) compared with children without AD.

Both children with and without AD most commonly tested positive for nickel as an allergen. Cobalt was also in the top five allergens for both groups, whereas fragrances (fragrance mix 1 and hydroperoxides of linalool), preservatives (methylchloroisothiazolinone and methylisothiazolinone) and neomycin were in the top 10.

Methylisothiazolinone was the second most common allergen in children with AD, whereas the fragrance balsam of Peru was the second most common in children without AD.

Children with AD were much more likely to be patch test-positive for certain allergens including bacitracin (OR = 3.23; 95% CI, 1.12-9.35), carba mix (OR = 3.36; 95% CI, 1.17-9.7) and cocamidopropyl betaine (OR = 3.69; 95% CI, 1.74-7.84).

“Children with AD develop more PPT reactions and are more likely to react to at least one or more allergens on patch testing than children without AD,” the authors concluded. “Our findings support the importance of referring children with AD for patch testing to consider ACD as an important comorbidity.”